Geode Capital Management’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-189,011
Closed -$3.47M 4520
2020
Q4
$3.47M Buy
189,011
+7,548
+4% +$139K ﹤0.01% 2791
2020
Q3
$3.33M Buy
181,463
+6,857
+4% +$126K ﹤0.01% 2621
2020
Q2
$2.61M Buy
174,606
+10,410
+6% +$156K ﹤0.01% 2699
2020
Q1
$2.6M Buy
164,196
+7,805
+5% +$123K ﹤0.01% 2534
2019
Q4
$2.54M Buy
156,391
+5,601
+4% +$90.9K ﹤0.01% 2866
2019
Q3
$2.24M Buy
150,790
+1,975
+1% +$29.3K ﹤0.01% 2884
2019
Q2
$2.46M Buy
148,815
+16,812
+13% +$278K ﹤0.01% 2816
2019
Q1
$2.28M Buy
132,003
+5,936
+5% +$103K ﹤0.01% 2782
2018
Q4
$2.23M Buy
126,067
+14,621
+13% +$258K ﹤0.01% 2719
2018
Q3
$2.02M Buy
111,446
+19,423
+21% +$352K ﹤0.01% 2874
2018
Q2
$1.8M Buy
92,023
+33,938
+58% +$663K ﹤0.01% 2913
2018
Q1
$1.02M Buy
58,085
+17,280
+42% +$303K ﹤0.01% 3114
2017
Q4
$463K Sell
40,805
-1,648
-4% -$18.7K ﹤0.01% 3383
2017
Q3
$452K Hold
42,453
﹤0.01% 3397
2017
Q2
$371K Sell
42,453
-18,993
-31% -$166K ﹤0.01% 3460
2017
Q1
$725K Buy
61,446
+1,030
+2% +$12.2K ﹤0.01% 3159
2016
Q4
$791K Buy
60,416
+3,517
+6% +$46K ﹤0.01% 3101
2016
Q3
$825K Buy
56,899
+1,477
+3% +$21.4K ﹤0.01% 3043
2016
Q2
$664K Buy
55,422
+3,170
+6% +$38K ﹤0.01% 3096
2016
Q1
$974 Buy
52,252
+523
+1% +$10 ﹤0.01% 2892
2015
Q4
$1.11M Buy
51,729
+1,580
+3% +$33.9K ﹤0.01% 2857
2015
Q3
$849K Buy
50,149
+11,889
+31% +$201K ﹤0.01% 2957
2015
Q2
$1.44M Buy
38,260
+11,226
+42% +$421K ﹤0.01% 2702
2015
Q1
$850K Buy
27,034
+10,009
+59% +$315K ﹤0.01% 2950
2014
Q4
$219K Buy
+17,025
New +$219K ﹤0.01% 3546